Tracing Skin Elements (ASX: SKN) latest progress in biotechnology space - Kalkine Media

Highlights

• The field of biotechnology is set to deliver "healthy lifestyle and healthy planet", Skin Elements mentions
• SKN has reiterated its commitment to safety and sustainability, thanks to its plant-based SE Formula™ technology
• SuprCuvr and Eco Nurture brands are starting phase 2 after having completed initial trials in cleaning and other applications

Skin Elements Limited (ASX: SKN) -- an Australian-listed biotechnology company into research & development of the SE Formula™ and its application in a wide range of products -- recently released its Annual General Meeting (AGM) presentation. Among other things, the presentation talked about how the field of biotechnology is set to deliver "healthy lifestyle and healthy planet", and the progress of SKN’s SE Formula™ technology.

The company has also reiterated its commitment to safety and sustainability, with its foundation built upon the principle of improving health and wellness of people "without harming our planet".

To know about SKN’s March quarter developments, click here.

Biotechnology and health

Skin Elements emphasises that there is a growing inclination in favour of sustainable consumption, with the worldwide adoption of technologies like renewable energy and electric vehicles serving as clear evidence. There is also growing evidence on the adverse effects on human body due to aggressive use of toxic chemicals and ingredients.

The ASX-listed company states it is at the forefront of the ongoing biotechnology revolution with the development of its “high performance” proprietary SE Formula™ technology, which is plant based and replaces toxic chemicals used in the skincare industry.

SKN has invested a considerable sum of AU$36 million in the research & development of the technology and development of its several applications. The company is working with a global network of partners including laboratories, regulators, and other stakeholders.

SE Formula™ technology and applications

The technology is based on Naturopathic principles, with SKN having used organic and natural ingredients.

The research & development has occurred over three phases -- first, an investigation into ingredients and processes for the preparation of prototype formulations; second, the production of test batches and product trials supported by regulatory certifications; and third, the scaling up of the technology and commercialisation.

Source: Company update

SKN's Soléo Organics has begun phase 3 in order to scale manufacturing of white label ranges for international retailers. PapayaActivs is finishing phase 2 with improvements marked in formulations and expansion. SuprCuvr and Eco Nurture are beginning phase 2 after having successfully completed multiple initial trials in cleaning and agricultural applications.

SKN ASX shares traded at AU$0.008 (market cap of AU$4.5 million) on 28 June 2023.